VS

Vineet Singh

Active Director Director DIN 09784826
DIN 09784826 First appointment Nov 2022 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2022
Shareholding value •••• Premium profile

About Vineet Singh

Data last updated:

Vineet Singh is a Director at Cdss Diagnostics Private Limited (since 2022). The company operates in Healthcare. Cdss Diagnostics Private Limited reported revenue of ₹5.4 Lakh (FY 2023).

DIN 09784826
Primary Designation Director
Industry Healthcare
First Appointment 09 Nov 2022
Oldest Company Age 3 yrs
Largest company Cdss Diagnostics Private Limited · ₹5.4 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cdss Diagnostics Private Limited U85110UP2022PTC173093
Director09 Nov 20222022₹5.4 Lakh (FY 2023)Active

Board colleagues of Vineet Singh

Directorship timeline

Open interactive timeline →
Cdss Diagnostics Private Limited
Premium access

Shareholding and investment profile for Vineet Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vineet Singh

Vineet Singh currently holds 1 directorship: Cdss Diagnostics Private Limited (Director, since 09 Nov 2022, revenue ₹5.4 Lakh (FY 2023)).

Vineet Singh was first appointed on 09 Nov 2022 as Director at Cdss Diagnostics Private Limited.

The current boards of Vineet Singh's companies include Ashish Kumar Mishra (Cdss Diagnostics Private Limited), Gulab Chandra Maurya (Cdss Diagnostics Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available